116 Evaluation of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in cervical cancer: data from phase 1 and phase 2 studies
Strauss, J, Braiteh, F, Calvo Aller, E, De Miguel, M, Cervantes, A, Edenfield, WJ, LI, T, Rasschaert, MA, Park-Simon, TW, Munoz, FL, Paz-Ares, L, Spira, A, Jehl, G, Dussault, I, Ojalvo, L, Gulley, J, Allan, S
Published in International journal of gynecological cancer (12.10.2021)
Published in International journal of gynecological cancer (12.10.2021)
Get full text
Journal Article
A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer
Trinh, X. B., Sas, L., Van Laere, S. J., Prove, A., Deleu, I., Rasschaert, M. A., Van De Velde, H., Vinken, P., Vermeulen, P. B., van Dam, P. A., Wojtasik, A., De Mesmaeker, P., Tjalma, W. A., Dirix, L. Y.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article